…was sold at auction to Martin Shkreli, founder of Turing Pharmaceuticals, for $2 million. Shkreli had gained notoriety in 2015 for buying the rights to Daraprim, a drug used by some AIDS and transplant patients, and then raising the price from $13.50 to $750 per pill. After learning that Shkreli…
Read More